⑴各种原因引起的生长激素缺乏性侏儒,包括垂体病变及其下丘脑病变所致者;
⑵儿童其他原因引起的矮小症,如特纳综合征,小于胎龄儿等;
⑶成人生长激素缺乏症、儿童特发性矮小等一些国家已批准使用;
⑷烧伤、儿童慢性肾衰等;
⑸用于Prader-Will综合征;【美国FDA已批准重组人生长激素注射液用于Prader-Will综合征;中华医学会儿科学分会内分泌遗传代谢学组《中华儿科杂志》编辑委员会,《基因重组人生长激素儿科临床规范应用的建议》(2013)】
...
Cook Childrens, Fort Worth, Texas, United States
Novo Nordisk Investigational Site, Toulouse cedex 9, France
Tongji Hospital, Tongji Medical College of HUST, Wuhan, Hubei, China
Fukuyama City Hospital, Fukuyama, Hiroshima, Japan
Hospital of the University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan
National Hospital Organization Kure Medical Center & Chugoku Cancer Center, Kure, Hiroshima, Japan
Hackensack University Medical Center, Hackensack, New Jersey, United States
Národný ústav detských chorôb, Detská klinika, Bratislava, Slovakia
Shriners Hospitals for Children, Tampa, Florida, United States
Odessa National Medical University, Odessa Regional Children's Hospital, Odessa, Ukraine
Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States
Novo Nordisk Investigational Site, Yokohama, Kanagawa, Japan
Severance Hospital, Seoul, Korea, Republic of
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.